Global ADHD Medications Market Growth (Status and Outlook) 2022-2028
- LP 4925778
- 89 Pages
- March 2022
- Pharmaceuticals
The United States ADHD Medications market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global ADHD Medications market, reaching US$ million by the year 2028. As for the Europe ADHD Medications landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main ADHD Medications players cover Amneal Pharmaceuticals, Eli Lilly and Co., Johnson and Johnson Services, and NEOS Therapeutic, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of ADHD Medications market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Stimulant
Non-stimulant
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Adult
Children
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Amneal Pharmaceuticals
Eli Lilly and Co.
Johnson and Johnson Services
NEOS Therapeutic
Takeda Pharmaceutical
Pfizer
Lupin
Shire
Mallinckrodt
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global ADHD Medications Market Size 2017-2028
2.1.2 ADHD Medications Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 ADHD Medications Segment by Type
2.2.1 Stimulant
2.2.2 Non-stimulant
2.3 ADHD Medications Market Size by Type
2.3.1 ADHD Medications Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global ADHD Medications Market Size Market Share by Type (2017-2022)
2.4 ADHD Medications Segment by Application
2.4.1 Adult
2.4.2 Children
2.5 ADHD Medications Market Size by Application
2.5.1 ADHD Medications Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global ADHD Medications Market Size Market Share by Application (2017-2022)
3 ADHD Medications Market Size by Player
3.1 ADHD Medications Market Size Market Share by Players
3.1.1 Global ADHD Medications Revenue by Players (2020-2022)
3.1.2 Global ADHD Medications Revenue Market Share by Players (2020-2022)
3.2 Global ADHD Medications Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 ADHD Medications by Regions
4.1 ADHD Medications Market Size by Regions (2017-2022)
4.2 Americas ADHD Medications Market Size Growth (2017-2022)
4.3 APAC ADHD Medications Market Size Growth (2017-2022)
4.4 Europe ADHD Medications Market Size Growth (2017-2022)
4.5 Middle East & Africa ADHD Medications Market Size Growth (2017-2022)
5 Americas
5.1 Americas ADHD Medications Market Size by Country (2017-2022)
5.2 Americas ADHD Medications Market Size by Type (2017-2022)
5.3 Americas ADHD Medications Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC ADHD Medications Market Size by Region (2017-2022)
6.2 APAC ADHD Medications Market Size by Type (2017-2022)
6.3 APAC ADHD Medications Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe ADHD Medications by Country (2017-2022)
7.2 Europe ADHD Medications Market Size by Type (2017-2022)
7.3 Europe ADHD Medications Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa ADHD Medications by Region (2017-2022)
8.2 Middle East & Africa ADHD Medications Market Size by Type (2017-2022)
8.3 Middle East & Africa ADHD Medications Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global ADHD Medications Market Forecast
10.1 Global ADHD Medications Forecast by Regions (2023-2028)
10.1.1 Global ADHD Medications Forecast by Regions (2023-2028)
10.1.2 Americas ADHD Medications Forecast
10.1.3 APAC ADHD Medications Forecast
10.1.4 Europe ADHD Medications Forecast
10.1.5 Middle East & Africa ADHD Medications Forecast
10.2 Americas ADHD Medications Forecast by Country (2023-2028)
10.2.1 United States ADHD Medications Market Forecast
10.2.2 Canada ADHD Medications Market Forecast
10.2.3 Mexico ADHD Medications Market Forecast
10.2.4 Brazil ADHD Medications Market Forecast
10.3 APAC ADHD Medications Forecast by Region (2023-2028)
10.3.1 China ADHD Medications Market Forecast
10.3.2 Japan ADHD Medications Market Forecast
10.3.3 Korea ADHD Medications Market Forecast
10.3.4 Southeast Asia ADHD Medications Market Forecast
10.3.5 India ADHD Medications Market Forecast
10.3.6 Australia ADHD Medications Market Forecast
10.4 Europe ADHD Medications Forecast by Country (2023-2028)
10.4.1 Germany ADHD Medications Market Forecast
10.4.2 France ADHD Medications Market Forecast
10.4.3 UK ADHD Medications Market Forecast
10.4.4 Italy ADHD Medications Market Forecast
10.4.5 Russia ADHD Medications Market Forecast
10.5 Middle East & Africa ADHD Medications Forecast by Region (2023-2028)
10.5.1 Egypt ADHD Medications Market Forecast
10.5.2 South Africa ADHD Medications Market Forecast
10.5.3 Israel ADHD Medications Market Forecast
10.5.4 Turkey ADHD Medications Market Forecast
10.5.5 GCC Countries ADHD Medications Market Forecast
10.6 Global ADHD Medications Forecast by Type (2023-2028)
10.7 Global ADHD Medications Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Amneal Pharmaceuticals
11.1.1 Amneal Pharmaceuticals Company Information
11.1.2 Amneal Pharmaceuticals ADHD Medications Product Offered
11.1.3 Amneal Pharmaceuticals ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Amneal Pharmaceuticals Main Business Overview
11.1.5 Amneal Pharmaceuticals Latest Developments
11.2 Eli Lilly and Co.
11.2.1 Eli Lilly and Co. Company Information
11.2.2 Eli Lilly and Co. ADHD Medications Product Offered
11.2.3 Eli Lilly and Co. ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Eli Lilly and Co. Main Business Overview
11.2.5 Eli Lilly and Co. Latest Developments
11.3 Johnson and Johnson Services
11.3.1 Johnson and Johnson Services Company Information
11.3.2 Johnson and Johnson Services ADHD Medications Product Offered
11.3.3 Johnson and Johnson Services ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Johnson and Johnson Services Main Business Overview
11.3.5 Johnson and Johnson Services Latest Developments
11.4 NEOS Therapeutic
11.4.1 NEOS Therapeutic Company Information
11.4.2 NEOS Therapeutic ADHD Medications Product Offered
11.4.3 NEOS Therapeutic ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 NEOS Therapeutic Main Business Overview
11.4.5 NEOS Therapeutic Latest Developments
11.5 Takeda Pharmaceutical
11.5.1 Takeda Pharmaceutical Company Information
11.5.2 Takeda Pharmaceutical ADHD Medications Product Offered
11.5.3 Takeda Pharmaceutical ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Takeda Pharmaceutical Main Business Overview
11.5.5 Takeda Pharmaceutical Latest Developments
11.6 Pfizer
11.6.1 Pfizer Company Information
11.6.2 Pfizer ADHD Medications Product Offered
11.6.3 Pfizer ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Pfizer Main Business Overview
11.6.5 Pfizer Latest Developments
11.7 Lupin
11.7.1 Lupin Company Information
11.7.2 Lupin ADHD Medications Product Offered
11.7.3 Lupin ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Lupin Main Business Overview
11.7.5 Lupin Latest Developments
11.8 Shire
11.8.1 Shire Company Information
11.8.2 Shire ADHD Medications Product Offered
11.8.3 Shire ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Shire Main Business Overview
11.8.5 Shire Latest Developments
11.9 Mallinckrodt
11.9.1 Mallinckrodt Company Information
11.9.2 Mallinckrodt ADHD Medications Product Offered
11.9.3 Mallinckrodt ADHD Medications Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Mallinckrodt Main Business Overview
11.9.5 Mallinckrodt Latest Developments
12 Research Findings and Conclusion
Table 1. ADHD Medications Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Stimulant
Table 3. Major Players of Non-stimulant
Table 4. ADHD Medications Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global ADHD Medications Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global ADHD Medications Market Size Market Share by Type (2017-2022)
Table 7. ADHD Medications Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global ADHD Medications Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global ADHD Medications Market Size Market Share by Application (2017-2022)
Table 10. Global ADHD Medications Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global ADHD Medications Revenue Market Share by Player (2020-2022)
Table 12. ADHD Medications Key Players Head office and Products Offered
Table 13. ADHD Medications Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global ADHD Medications Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global ADHD Medications Market Size Market Share by Regions (2017-2022)
Table 18. Americas ADHD Medications Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas ADHD Medications Market Size Market Share by Country (2017-2022)
Table 20. Americas ADHD Medications Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas ADHD Medications Market Size Market Share by Type (2017-2022)
Table 22. Americas ADHD Medications Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas ADHD Medications Market Size Market Share by Application (2017-2022)
Table 24. APAC ADHD Medications Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC ADHD Medications Market Size Market Share by Region (2017-2022)
Table 26. APAC ADHD Medications Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC ADHD Medications Market Size Market Share by Type (2017-2022)
Table 28. APAC ADHD Medications Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC ADHD Medications Market Size Market Share by Application (2017-2022)
Table 30. Europe ADHD Medications Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe ADHD Medications Market Size Market Share by Country (2017-2022)
Table 32. Europe ADHD Medications Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe ADHD Medications Market Size Market Share by Type (2017-2022)
Table 34. Europe ADHD Medications Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe ADHD Medications Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa ADHD Medications Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa ADHD Medications Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa ADHD Medications Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa ADHD Medications Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa ADHD Medications Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa ADHD Medications Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of ADHD Medications
Table 43. Key Market Challenges & Risks of ADHD Medications
Table 44. Key Industry Trends of ADHD Medications
Table 45. Global ADHD Medications Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global ADHD Medications Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global ADHD Medications Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global ADHD Medications Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global ADHD Medications Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global ADHD Medications Market Size Market Share Forecast by Application (2023-2028)
Table 51. Amneal Pharmaceuticals Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 52. Amneal Pharmaceuticals ADHD Medications Product Offered
Table 53. Amneal Pharmaceuticals ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Amneal Pharmaceuticals Main Business
Table 55. Amneal Pharmaceuticals Latest Developments
Table 56. Eli Lilly and Co. Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 57. Eli Lilly and Co. ADHD Medications Product Offered
Table 58. Eli Lilly and Co. Main Business
Table 59. Eli Lilly and Co. ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Eli Lilly and Co. Latest Developments
Table 61. Johnson and Johnson Services Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 62. Johnson and Johnson Services ADHD Medications Product Offered
Table 63. Johnson and Johnson Services Main Business
Table 64. Johnson and Johnson Services ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Johnson and Johnson Services Latest Developments
Table 66. NEOS Therapeutic Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 67. NEOS Therapeutic ADHD Medications Product Offered
Table 68. NEOS Therapeutic Main Business
Table 69. NEOS Therapeutic ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. NEOS Therapeutic Latest Developments
Table 71. Takeda Pharmaceutical Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 72. Takeda Pharmaceutical ADHD Medications Product Offered
Table 73. Takeda Pharmaceutical Main Business
Table 74. Takeda Pharmaceutical ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Takeda Pharmaceutical Latest Developments
Table 76. Pfizer Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 77. Pfizer ADHD Medications Product Offered
Table 78. Pfizer Main Business
Table 79. Pfizer ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Pfizer Latest Developments
Table 81. Lupin Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 82. Lupin ADHD Medications Product Offered
Table 83. Lupin Main Business
Table 84. Lupin ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Lupin Latest Developments
Table 86. Shire Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 87. Shire ADHD Medications Product Offered
Table 88. Shire Main Business
Table 89. Shire ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Shire Latest Developments
Table 91. Mallinckrodt Details, Company Type, ADHD Medications Area Served and Its Competitors
Table 92. Mallinckrodt ADHD Medications Product Offered
Table 93. Mallinckrodt Main Business
Table 94. Mallinckrodt ADHD Medications Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Mallinckrodt Latest Developments
List of Figures
Figure 1. ADHD Medications Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global ADHD Medications Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global ADHD Medications Market Size Market Share by Type in 2021
Figure 7. ADHD Medications in Adult
Figure 8. Global ADHD Medications Market: Adult (2017-2022) & ($ Millions)
Figure 9. ADHD Medications in Children
Figure 10. Global ADHD Medications Market: Children (2017-2022) & ($ Millions)
Figure 11. Global ADHD Medications Market Size Market Share by Application in 2021
Figure 12. Global ADHD Medications Revenue Market Share by Player in 2021
Figure 13. Global ADHD Medications Market Size Market Share by Regions (2017-2022)
Figure 14. Americas ADHD Medications Market Size 2017-2022 ($ Millions)
Figure 15. APAC ADHD Medications Market Size 2017-2022 ($ Millions)
Figure 16. Europe ADHD Medications Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa ADHD Medications Market Size 2017-2022 ($ Millions)
Figure 18. Americas ADHD Medications Value Market Share by Country in 2021
Figure 19. Americas ADHD Medications Consumption Market Share by Type in 2021
Figure 20. Americas ADHD Medications Market Size Market Share by Application in 2021
Figure 21. United States ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC ADHD Medications Market Size Market Share by Region in 2021
Figure 26. APAC ADHD Medications Market Size Market Share by Application in 2021
Figure 27. China ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 31. India ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe ADHD Medications Market Size Market Share by Country in 2021
Figure 34. Europe ADHD Medications Market Size Market Share by Type in 2021
Figure 35. Europe ADHD Medications Market Size Market Share by Application in 2021
Figure 36. Germany ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 37. France ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa ADHD Medications Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa ADHD Medications Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa ADHD Medications Market Size Market Share by Application in 2021
Figure 44. Egypt ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country ADHD Medications Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 50. APAC ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 51. Europe ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 53. United States ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 54. Canada ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 55. Mexico ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 56. Brazil ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 57. China ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 58. Japan ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 59. Korea ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 61. India ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 62. Australia ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 63. Germany ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 64. France ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 65. UK ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 66. Italy ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 67. Russia ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 68. Spain ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 69. Egypt ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 70. South Africa ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 71. Israel ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 72. Turkey ADHD Medications Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries ADHD Medications Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
